Parametric Portfolio Associates LLC raised its holdings in Cooper Companies Inc (NYSE:COO) by 17.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 71,701 shares of the medical device company’s stock after purchasing an additional 10,677 shares during the period. Parametric Portfolio Associates LLC owned 0.15% of Cooper Companies worth $17,001,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of COO. Advisory Services Network LLC boosted its position in shares of Cooper Companies by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after acquiring an additional 107 shares during the period. YorkBridge Wealth Partners LLC boosted its position in shares of Cooper Companies by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after acquiring an additional 11 shares during the period. Acrospire Investment Management LLC boosted its position in shares of Cooper Companies by 50.0% in the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock valued at $144,000 after acquiring an additional 200 shares during the period. Canada Pension Plan Investment Board bought a new position in shares of Cooper Companies in the third quarter valued at approximately $163,000. Finally, Edgestream Partners L.P. bought a new position in shares of Cooper Companies in the second quarter valued at approximately $214,000. Hedge funds and other institutional investors own 96.73% of the company’s stock.
Shares of Cooper Companies Inc (COO) opened at $230.84 on Friday. The firm has a market cap of $11,280.00, a P/E ratio of 30.70, a PEG ratio of 1.86 and a beta of 0.54. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a 1-year low of $177.06 and a 1-year high of $256.39.
Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. The firm had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.28 EPS. research analysts predict that Cooper Companies Inc will post 11.51 earnings per share for the current year.
The firm also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd will be issued a $0.03 dividend. The ex-dividend date is Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s payout ratio is 0.80%.
In other news, CEO Robert S. Weiss sold 32,500 shares of the business’s stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $224.70, for a total value of $7,302,750.00. Following the completion of the sale, the chief executive officer now directly owns 119,111 shares in the company, valued at approximately $26,764,241.70. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Allan E. Rubenstein sold 500 shares of the business’s stock in a transaction that occurred on Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total transaction of $111,000.00. Following the completion of the sale, the director now owns 6,590 shares of the company’s stock, valued at $1,462,980. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 47,935 shares of company stock valued at $10,813,768. Company insiders own 1.60% of the company’s stock.
A number of equities analysts have recently commented on COO shares. Zacks Investment Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday, September 18th. BMO Capital Markets restated a “buy” rating and issued a $272.00 price objective on shares of Cooper Companies in a research report on Friday, October 13th. Robert W. Baird set a $273.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a research report on Monday, October 16th. KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, October 20th. Finally, Raymond James Financial reiterated a “buy” rating and set a $265.00 target price on shares of Cooper Companies in a research report on Monday, December 4th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $259.70.
WARNING: This story was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://ledgergazette.com/2018/01/13/parametric-portfolio-associates-llc-raises-holdings-in-cooper-companies-inc-coo.html.
Cooper Companies Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.